Ribbon Biolabs
Status
ACTIVE
Global HQ
Austria
Countries of investment
- USA
Investment stages
- Seed
- Series A
Industries
- Fintech
- Web3
About
Ribbon Biolabs revolutionizes DNA synthesis with cutting-edge technology, empowering biotech industry and academia to innovate and tackle challenges in synthetic biology.
Ribbon Biolabs revolutionizes DNA synthesis with cutting-edge technology, empowering biotech industry and academia to innovate and tackle challenges in synthetic biology.
Investment Thesis
Ribbon Biolabs focuses on developing revolutionary technology for the fast and efficient automated synthesis of DNA, making complex DNA accessible and affordable for customers in the biotech industry and academia.
Manager's Experience
With a robust background in venture capital, the fund manager has actively participated in over 50 investments across the biotechnology and healthcare sectors. This individual specializes in early-stage opportunities, emphasizing a data-driven approach to identify transformative innovations. Their strategic style is characterized by a thematic focus on disruptive technologies, particularly within North America and Europe. Notable exits include several high-profile acquisitions, underscoring their adeptness at navigating complex market landscapes.
Ribbon Biolabs Contacts Information
Primary contact
Team
Lukas Leiendecker